Hong Kong Oil and Gas Stock News

SEHK:3
SEHK:3Gas Utilities

Hong Kong And China Gas (SEHK:3) Margin Stability Tests Bullish Narratives In FY 2025 Earnings

Setting the Scene: Hong Kong and China Gas FY 2025 Results Hong Kong and China Gas (SEHK:3) has put fresh numbers on the table for FY 2025, with first half revenue of HK$27.5 billion and basic EPS of HK$0.16 anchoring the latest set of results. Looking back at recent periods, revenue has held close to HK$27.5 billion across the last three halves, while basic EPS has moved between HK$0.14 and HK$0.16. This gives a clear line of sight on how the top line and per share earnings have been...
SEHK:34
SEHK:34Real Estate

Kowloon Development (SEHK:34) One Off HK$495.6M Loss Tests Bullish Narratives

Kowloon Development (SEHK:34) has released its FY 2025 scorecard, reporting first half revenue of HK$2.4b and basic EPS of HK$0.10, alongside trailing 12-month earnings growth of 12.9% and a net profit margin of 2.6%. Over recent reporting periods, revenue moved from HK$1.9b in 1H FY 2024 to HK$3.4b in 2H FY 2024 and HK$2.4b in 1H FY 2025. Basic EPS shifted from HK$0.10 in 1H FY 2024 to HK$0.00 in 2H FY 2024 and back to HK$0.10 in 1H FY 2025. Taken together, these figures highlight modest...
SEHK:336
SEHK:336Chemicals

Huabao International Holdings (SEHK:336) Half Year Profit Challenges Long Running Loss Narrative

Huabao International Holdings (SEHK:336) has just released its FY 2025 first half scorecard, with revenue of C¥1,621.2 million and basic EPS of C¥0.0366, set against trailing twelve month figures that still reflect net losses. Over recent periods, revenue has moved between C¥1,582.3 million and C¥1,790.98 million per half year while basic EPS has ranged from C¥0.0092 to a loss of C¥0.1285. This gives a clear view of how the top line has held up as earnings have come under pressure. For...
SEHK:878
SEHK:878Real Estate

Soundwill Holdings (SEHK:878) Losses Deepen To HK$1.34b In 1H 2025 Reinforcing Bearish Narratives

Soundwill Holdings (SEHK:878) has reported FY 2025 first half revenue of HK$180.7 million and a basic EPS loss of HK$4.72 per share, with trailing twelve month figures showing revenue of HK$358.2 million and a net income loss of HK$2.1 billion. Over the past few reporting halves, the company has seen revenue move from HK$1,030.1 million in 1H 2024 to HK$199.6 million in 2H 2024 and HK$180.7 million in 1H 2025, while basic EPS shifted from a loss of HK$3.44 to HK$5.35 and then HK$4.72. For...
SEHK:687
SEHK:687Construction

Tysan Holdings (SEHK:687) Earnings Jump Reinforces Bullish Narrative On Thin 3% Net Margin

Tysan Holdings (SEHK:687) has just reported its FY 2025 first half numbers, with revenue of HK$1.2b and basic EPS of HK$0.010142, setting the tone for how the year is shaping up. The company has seen revenue move from HK$1,009.4m in 1H FY 2024 to HK$1,150.3m in 1H FY 2025, while basic EPS has gone from HK$0.00318 to HK$0.010142 over the same stretch, giving a clear view of how the top and bottom lines are tracking year on year. With trailing 12 month net margin at 3%, the latest results...
SEHK:32
SEHK:32Consumer Services

Cross Harbour SEHK 32 Margin Surge Reinforces Bullish Earnings Narratives

Cross-Harbour (Holdings) (SEHK:32) has reported FY 2025 first half revenue of HK$825.3 million, with basic EPS of HK$1.34 and trailing twelve month EPS of HK$1.89, set against reported earnings growth of 63.5% over the past year. The company has seen revenue move from HK$586.99 million in 1H 2024 to HK$638.34 million in 2H 2024 and then to HK$825.3 million in 1H 2025. Trailing twelve month net income excluding extra items has reached HK$704.84 million, giving investors a results set framed by...
SEHK:1168
SEHK:1168Real Estate

Z Fin (SEHK:1168) Net Loss Of HK$507 Million Revives Concerns Over Earnings Volatility

Z Fin (SEHK:1168) has put out a mixed FY 2025 print, with first half revenue of HK$280.3 million and a basic EPS loss of HK$1.59, against a trailing 12 month picture that shows HK$566.0 million of revenue and a basic EPS loss of HK$2.97. Over recent periods the company has seen revenue move from HK$103.4 million in the first half of FY 2024 to HK$172.4 million in the second half and then to HK$280.3 million in the first half of FY 2025, while basic EPS has swung between a loss of HK$0.47, a...
SEHK:6811
SEHK:6811Hospitality

Tai Hing Group (SEHK:6811) Margin Gains Reinforce Bullish Narratives Despite One Off Drag

Tai Hing Group Holdings (SEHK:6811) has just wrapped up FY 2025 with first half revenue of HK$1,712.2 million and basic EPS of HK$0.0419, setting the tone for how the rest of the year could shape investor expectations. The company has seen revenue progress from HK$1,612.5 million in 1H 2024 to HK$1,679.5 million in 2H 2024 and HK$1,712.2 million in 1H 2025, while basic EPS moved from HK$0.0107 to HK$0.0518 and then HK$0.0419 over the same periods. With net profit margin higher over the last...
SEHK:1224
SEHK:1224Real Estate

C C Land Holdings (SEHK:1224) Half Year Loss Tests Bullish Narratives On Premium 8.5x P/S

C C Land Holdings (SEHK:1224) has reported its FY 2025 first half results with revenue of HK$250.3 million and a basic EPS loss of HK$0.0095, while trailing twelve month figures show revenue of HK$546.3 million and a basic EPS loss of HK$0.1202 as the company remains unprofitable. Over the past three reported halves, revenue has moved from HK$244.1 million in 1H FY 2024 to HK$264.2 million in 2H FY 2024 and then HK$250.3 million in 1H FY 2025. EPS shifted from a profit of HK$0.0234 in 1H FY...
SEHK:6826
SEHK:6826Biotechs

Haohai BioTech SEHK 6826 One Off C¥167.7m Loss Tests Bullish Earnings Narratives

Shanghai Haohai Biological Technology (SEHK:6826) has wrapped up FY 2025 with fourth quarter revenue of C¥573.9 million and a basic EPS loss of C¥0.23, while the trailing twelve month basic EPS sits at C¥1.08 on revenue of about C¥2.5 billion. Over recent periods the company has seen quarterly revenue move between C¥573.9 million and C¥685.9 million, with basic EPS ranging from a loss of C¥0.23 to a profit of C¥0.52. This presents a mixed earnings picture across the year. With a trailing net...
SEHK:570
SEHK:570Pharmaceuticals

China Traditional Chinese Medicine (SEHK:570) Half Year Loss Challenges Turnaround Narrative

China Traditional Chinese Medicine Holdings (SEHK:570) has reported its FY 2025 first half results with revenue of C¥7.5b and a basic EPS loss of C¥0.02, while the trailing twelve months show revenue of C¥14.7b and a basic EPS loss of C¥0.07. Over recent half year periods, revenue has moved from C¥8.4b with EPS of C¥0.04 in 1H 2024 to C¥8.1b with an EPS loss of C¥0.03 in 2H 2024, then to C¥7.5b with an EPS loss of C¥0.02 in 1H 2025, setting up a story where investors are weighing weaker...
SEHK:2380
SEHK:2380Renewable Energy

China Power International Development (SEHK:2380) Margin Improvement Tests Bullish Growth Narratives

China Power International Development (SEHK:2380) has released its FY 2025 results with first half revenue of C¥24.7b and basic EPS of C¥0.21, while trailing twelve month revenue sits at C¥53.0b with EPS of C¥0.24. Over recent periods, the company has seen revenue move from C¥27.2b in 1H 2024 to C¥29.1b in 2H 2024 and then C¥24.7b in 1H 2025, alongside basic EPS figures of C¥0.21, C¥0.06 and C¥0.21 respectively. This sets up a picture where modest earnings growth and slightly stronger net...
SEHK:2602
SEHK:2602Real Estate

Onewo (SEHK:2602) EPS Rebound To C¥0.68 Tests Bearish Margin Narratives

Onewo (SEHK:2602) has reported its FY 2025 first half results with revenue of C¥18.1b and basic EPS of C¥0.68, setting the tone for how the rest of the year could shape expectations around earnings quality. Over the last three reported half year periods, revenue has moved from C¥17.6b in 1H 2024 to C¥18.7b in 2H 2024 and C¥18.1b in 1H 2025, while basic EPS printed at C¥0.65, C¥0.32 and C¥0.68 across those same periods. This gives investors a clear view of how the top line and per share profit...
SEHK:28
SEHK:28Real Estate

Tian An China Investments (SEHK:28) Swings To HK$2.3b Profit Challenging Bearish Narratives

Tian An China Investments (SEHK:28) has opened FY 2025 with first half revenue of HK$8.7b and basic EPS of HK$1.60, against a backdrop where the trailing twelve months show revenue of HK$10.5b and EPS of HK$1.21 as the company has moved from a prior loss to profit over the last year. Over recent periods, revenue has shifted from HK$1.5b in the first half of FY 2024 to HK$1.5b in the second half, before stepping up to HK$8.7b in the first half of FY 2025. Over the same periods, EPS moved from...
SEHK:1979
SEHK:1979Electrical

Ten Pao Group Holdings FY 2025 Margin Slippage Tests Bullish Earnings Narratives

Ten Pao Group Holdings (SEHK:1979) has posted its FY 2025 first half results with revenue of HK$2.95b and basic EPS of HK$0.21, giving investors a fresh look at how the business is converting its top line into earnings. The company has seen revenue move from HK$2.47b in the first half of FY 2024 to HK$2.91b in the second half and HK$2.95b in the first half of FY 2025, while basic EPS has shifted from HK$0.17 to HK$0.20 and now HK$0.21 over the same periods. This sets up a results season where...
SEHK:255
SEHK:255Machinery

Lung Kee Group (SEHK:255) Loss In Latest Half Reinforces Concerns Over Earnings Weakness

Lung Kee Group Holdings (SEHK:255) has posted its FY 2025 first half results with revenue of HK$688.7 million and a basic EPS loss of HK$0.0056, while trailing twelve month figures show revenue of HK$1.3 billion and a basic EPS loss of HK$0.0358. Over recent periods, the company has seen revenue move from HK$785.2 million and HK$769.1 million in the first and second halves of FY 2024 to HK$688.7 million in the latest half, with EPS swinging between losses and modest profits across those...
SEHK:2282
SEHK:2282Hospitality

MGM China Holdings (SEHK:2282) Margin Stability Tests Bullish Growth Narratives

Earnings snapshot and recent momentum MGM China Holdings (SEHK:2282) has put fresh numbers on the board for FY 2025, with first half revenue of about HK$16.7b, basic EPS of HK$0.63 and net income of HK$2.4b setting the tone for the year. The business has seen revenue move from roughly HK$16.2b in 1H 2024 to HK$15.2b in 2H 2024 and then to HK$16.7b in 1H 2025, while basic EPS shifted from HK$0.71 to HK$0.50 and then HK$0.63 over the same periods. This gives a clear sense of how headline growth...
SEHK:6862
SEHK:6862Hospitality

Haidilao’s World’s Strongest Brand Title Versus Its Tougher Share Record

Haidilao International Holding has been named the World’s Strongest Restaurant Brand for 2024. The recognition highlights the company’s brand strength beyond its usual financial headlines. The stock, traded under ticker SEHK:6862, last closed at HK$15.85. For investors tracking SEHK:6862, this brand accolade arrives after a mixed share price record. The stock is up 10.0% year to date, while the 1 year return stands at a 2.6% decline and the 5 year return at a 64.6% decline, with the current...
SEHK:1044
SEHK:1044Personal Products

Assessing Hengan International Group (SEHK:1044) Valuation After Full-Year 2025 Earnings And Final Dividend Announcement

Hengan International Group (SEHK:1044) is back in focus after releasing its full year 2025 results and proposing a final ordinary dividend of RMB 0.7 per share for the period. See our latest analysis for Hengan International Group. At a share price of HK$27.38, Hengan International Group has a 1-year total shareholder return of 29.37%, despite a 30-day share price return decline of 6.81% and a 5-year total shareholder return decline of 30.56%. This points to improving momentum more recently...
SEHK:1211
SEHK:1211Auto

BYD’s Brazil Expansion Adds New Layer To Global EV Capacity Story

BYD (SEHK:1211) is investing in a new automotive testing and evaluation center in Rio de Janeiro, Brazil. The company is also expanding local assembly operations in Brazil, with plans to double assembly capacity. These Brazil investments focus on R&D and production for electric vehicles and have not been covered in earlier reports. BYD, a major electric vehicle and battery producer, has been growing its presence in global EV markets, and Brazil is emerging as a key part of that story. The...
SEHK:1
SEHK:1Industrials

CK Hutchison Holdings FY 2025 EPS Rebound Tests Bearish Earnings Quality Narrative

CK Hutchison Holdings (SEHK:1) FY 2025 earnings at a glance CK Hutchison Holdings (SEHK:1) has wrapped up FY 2025 with second half revenue of HK$140.9b, net income of HK$10,989m and basic EPS of HK$2.87, setting the tone for how investors parse a year that also carried a large one off loss in the background. Over recent reporting periods, the company has seen revenue shift from HK$144.9b and EPS of HK$1.80 in 2H 2024 to HK$139.1b and EPS of HK$0.22 in 1H 2025, before landing at HK$140.9b and...
SEHK:2883
SEHK:2883Energy Services

A Look At China Oilfield Services’ Valuation After Its New CNY 5b Debt Refinancing Move

Why China Oilfield Services’ new CNY 5b notes matter for shareholders China Oilfield Services (SEHK:2883) has issued CNY 5b in new notes, with most of the proceeds earmarked for refinancing existing debt and general corporate use. This financing move can influence how investors view balance sheet risk. See our latest analysis for China Oilfield Services. The new CNY 5b notes come as China Oilfield Services’ share price has climbed to HK$9.57, with a 90 day share price return of 38.49% and a 1...
SEHK:3988
SEHK:3988Banks

Assessing Bank Of China (SEHK:3988) Valuation After Recent Share Price Momentum

Framing the recent move in Bank of China shares Bank of China (SEHK:3988) has stayed on investors’ radar after recent share price moves, with returns of 0.6% over the past day and 3.3% over the past week drawing attention to its fundamentals. See our latest analysis for Bank of China. At the current share price of HK$4.7, the recent 3.3% 7 day share price return continues a trend that has given Bank of China a 6.3% 90 day share price return and an 8.3% 1 year total shareholder return. This...
SEHK:1952
SEHK:1952Biotechs

A Look At Everest Medicines (SEHK:1952) Valuation After Recent Share Price Pullback

Everest Medicines share performance context Everest Medicines (SEHK:1952) has drawn attention after a sharp share price pullback, with the stock showing a 4.0% decline over the past day and a 32.6% decline over the past 3 months. See our latest analysis for Everest Medicines. The recent 4.0% one day share price decline and 15.9% 30 day share price return, combined with a 47.3% 1 year total shareholder return loss, point to fading momentum despite a very large 3 year total shareholder return...